Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 269-304-0 | CAS number: 68214-62-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
The test item is “non-mutagenic” in the Bacterial Reverse Mutation Test, up to the highest tested concentration of 5 mg/plate and under the tested conditions.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From December 19th 2017 to January 9th 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- adopted on 21st July 1997
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Details on mammalian cell type (if applicable):
- CELLS USED
- Source of cells: Molecular Toxicology, Inc. PO Box 1189 Boone, NC 28607 USA.
- Storage: stock cultures of tester strains in oxoid nutrient broth no. 2 were stored in the test facility as frozen permanents in -80 ± 10 °C. Laboratory stocks of each strain were maintained on minimal glucose agar as master plates. These master plates were stored in a refrigerator between 2 to 8 °C for 3 months .
- Culturing: each of the tester strains from the master plates were grown in oxoid nutrient broth no. 2. A fresh culture of bacteria was grown up to late exponential or early stationary phase of growth. The inoculum was incubated in a water bath at 37 ±1 °C for 15 hrs and 7 minutes for initial cytotoxicity, 15 hrs and 14 minutes for plate incorporation method for pre incubation method. The inoculum was adjusted to a density of 18×10^8 cells/ml.
GENETIC CHARACTERIZATION OF TESTER STRAINS
After preparation of the master plates, the growth requirements and the genetic identity of Salmonella typhimurium strains like histidine requirement, sensitivity to UV radiation, resistance of strains TA 98, TA 100 and TA102 to ampicillin, resistance of TA102 for tetracycline and rfa mutation of Salmonella typhimurium strains were checked along with the range of spontaneous revertants. - Metabolic activation:
- with and without
- Metabolic activation system:
- rat liver S9 homogenate
- Test concentrations with justification for top dose:
- MAIN EXPERIMENTS Plate Incorporation Method and Preincubation Method: 0.05, 0.16, 0.5, 1.6 and 5 mg/plate, with and without S9
PRELIMINARY CYTOTOXICITY TEST: 0.5, 0.6, 0.7, 0.8, 0.9, 1, 2, 3, 4 and 5 mg/plate of test item, with and without S9 - Vehicle / solvent:
- - Solvent: the test item formed uniform suspension in dimethyl sulphoxide at 50 mg/ml.
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- 2-nitrofluorene
- sodium azide
- mitomycin C
- other: 2-Aminoanthracene
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: plate incorporation method and pre incubation method.
Plate incorporation
- Plate composition: 2.0 ml soft agar containing histidine-biotin, 500 µl S9 mix or 500 µl Phosphate Buffer Saline (PBS), 100 µl test concentrations /vehicle/ appropriate positive control, 100 µl bacterial culture (containing approximately 10^8 viable cells).
- PIncubation: at 37 ± 1 °C
- Incubation period: 48 hrs and 15 mins.
Preincubation Method
- Plate composition: 500 µl S9 mix or 500 µl Phosphate Buffer Saline (PBS), 100 µl test concentrations /vehicle/ appropriate positive control, 100 µl bacterial culture (containing approximately 10^8 viable cells).
- Incubation: at 37 ± 1 °C
- Incubation period: 30 minutes.
- Post incubation: the test constituents were mixed with 2 ml soft agar and poured on to minimal glucose agar plates.
- Second incubation: plates were incubated at 37 ± 1°C
- Second incubation period: 48 hrs and 5 mins.
VIABLE COUNT
The bacterial suspension of each tester strain was diluted up to 10^-7 in phosphate buffer saline and 1000 µl of the diluted suspension from each tester strain was plated onto nutrient agar plates in triplicate. The plates were incubated at 37 ± 1 °C for 47 hours and 12 mins for plate incorporation method for pre incubation method. After incubation, the number of colonies in each plate were counted manually and expressed as number of Colony Forming Units per ml (CFU/ml) of the bacterial suspension.
PRELIMINARY CYTOTOXICITY TEST
- Test strains: Salmonella typhimurium TA100.
- Replicates: in triplicate.
- Plate composition: each concentration of test item was mixed with soft agar containing histidine and biotin, S9 mix (for presence of metabolic activation), phosphate buffer saline (for absence of metabolic activation), Salmonella typhimurium TA100 cells and overlaid on to prelabeled minimal glucose agar plates.
- Cell density: approximately 18 × 10^8 cells/ml.
- Incubation consitions: the plates were incubated at 37 ± 1 °C for 48 hrs and 15 mins.
- Incubation period: 48 hrs and 15 mins.
PRECIPITATION TEST
Stock solution of test item was serially diluted to get different concentrations of 0.5, 0.6, 0.7, 0.8, 0.9, 1, 2, 3, 4 and 5 mg/plate using dimethyl sulphoxide. A quantity of 100 µl of different concentrations of test item was separately mixed with 2 ml of molten soft agar, vortexed and spread onto minimal glucose agar plates. Plates were incubated for 2 hrs at 37 ± 1 °C.
PREPARATION OF S9 HOMOGENATE AND ACTIVATION MIXTURE
The S9 homogenate was prepared from male Wistar rats induced with intraperitoneal injection of sodium phenobarbitone and β-Naphthoflavone at 16 mg/ml and 20 mg/ml respectively, for 3 days prior to sacrifice.
The S9 homogenate was prepared and stored in the test facility at -80 ± 10 °C until use. Each batch of S9 homogenate was assessed for sterility by streaking the supernatant fluid on Nutrient Agar plates and incubated at 37 ± 1 °C for 48 hours. It was found sterile and was further evaluated for its protein content and for its ability to metabolize the promutagens 2-Aminoanthracene and Benzo(a)pyrene to mutagens using Salmonella typhimurium TA100. The results were found to be acceptable for the tested parameters.
A volume of 1 ml of S9 homogenate was thawed immediately before use and mixed with 9 ml of co-factor solution containing 4 mM Nicotinamide Adenine Dinucleotide Phosphate (NADP) disodium salt, 5 mM Glucose-6-phosphate, 8 mM MgCl2 and 33 mM KCl in Phosphate Buffer Saline (PBS) of pH 7.33 for initial cytotoxicity and plate incorporation and 7.28 for preincubation method to get the concentration of 10 % (v/v).
CRITERIA FOR ACCEPTABILITY OF THE TEST
The mutation test is considered acceptable as it meets the following criteria:
- All tester strains confirmed to their genetic characteristics.
- The positive controls showed increase in revertant colony numbers of at least twice or thrice the concurrent vehicle control levels with the appropriate bacterial strain. - Evaluation criteria:
- The conditions necessary for determining a positive result are: there should be a dose related increase over the range tested and/or a reproducible increase in the mean revertants per plate of at least one tester strain over a minimum of two increasing doses of the test item, either in the presence or absence of the metabolic activation system.
The test will be judged positive if the increase in mean revertants at the peak of the dose response is equal to or greater than 2 times the mean vehicle control value in Salmonella typhimurium strains TA98, TA100 and TA102 or equal to or greater than 3 times the mean vehicle control value in tester strains TA1535 and TA1537.
An equivocal response is a biologically relevant increase in a revertant count that partially meets the criteria for evaluation as positive. This could be a dose responsive increase that does not achieve the respective threshold cited above or a non dose responsive increase that is equal to or greater than the respective threshold cited. A response will be evaluated as negative, if it is neither positive nor equivocal. - Species / strain:
- S. typhimurium, other: TA 98, TA 100, TA 102, TA 1535, and TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Plate incorporation method
All the tester strains treated all the concentrations showed very close resemblance to the vehicle control when tested with and without metabolic activation. There was no appreciable increase in number of revertant colonies and no change in bacterial background lawn when compared to that of the vehicle control, among the tester strains. The mean number of revertant colonies/plate and bacterial background lawn in the treatment groups for the tested strains were comparable to that of vehicle control.
The specific positive controls tested simultaneously produced approximately 2.1 to 16.7 fold increase in mean number of revertants as compared to the vehicle control.
Preincubation method
All the tester strains treated at all the concentrations showed very close resemblance to the vehicle control when tested with and without metabolic activation. There was no appreciable increase in number of revertant colonies and no change in bacterial background lawn when compared to that of the vehicle control, among the tester strains. The mean number of revertant colonies/plate and bacterial background lawn in the treatment groups for the tested strains were comparable to that of vehicle control.
The specific positive controls tested simultaneously produced approximately 2.1 to 18.3 fold increase in mean number of revertants as compared to the vehicle control.
VIABLE COUNT
Each tester strain was serially diluted to 10^-7 and plated on nutrient agar. After 47 hrs 12 mins of incubation for plate incorporation method and for pre incubation method, the numbers of colonies were counted manually and results were expressed as Colony Forming Units (CFU). Each tester strains resulted in acceptable range of 1 to 2 × 10^9 CFU/ml.
PRELIMINARY CYTOTOXICITY TEST
The tester strain exposed with test item in the presence and absence of metabolic activation system resulted in no cytotoxicity when compared to vehicle control. On the basis of cytotoxicity results 5 mg/plate was considered as the highest test concentration for mutation assay.
PRECIPITATION TEST
The test item resulted in minimal precipitation at 4 and 5 mg/plate and no precipitation up to 0.5 mg/plate.
SOLUBILITY TEST
The test item formed suspension in dimethyl sulphoxide at a concentration of 50 mg/ml. - Conclusions:
- It can be concluded that the test item is “non-mutagenic” in the Bacterial Reverse Mutation Test, up to the highest tested concentration of 5 mg/plate and under the tested conditions
- Executive summary:
The test item was evaluated for mutagenicity in Bacterial Reverse Mutation Test, according to OECD guideline 471 (1997).
On the basis of test item solubility and precipitation tests, the initial cytotoxicity test was performed at 0.5, 0.6, 0.7, 0.8, 0.9, 1, 2, 3, 4 and 5 mg/plate. Initial cytotoxicity test was performed with TA100 both in the presence and absence of metabolic activation system. The tester strain, TA100 treated with test item, in the presence and absence of metabolic activation system, didn't show cytotoxicity when compared to vehicle control. On the basis of cytotoxicity results, 5 mg/plate was considered as the highest test concentration for mutation assay.
The test concentrations tested in the mutation assay were selected based on the results of solubility, precipitation and initial cytotoxicity test. The two independent trials (trial 1 and 2) were conducted by plate incorporation and pre incubation methods in the presence and absence of metabolic activation system. In mutation assay, the test item was tested at the concentrations of 0.05, 0.16, 0.5, 1.6 and 5 mg/plate. Vehicle control (dimethyl sulphoxide) and appropriate positive controls (2-nitrofluorene, sodium azide and 9-Aminoacridine, Mitomycin C for trials “without metabolic activation” and 2-Aminoanthracene for trials “with metabolic activation”) were tested simultaneously. The tester strains used in the mutation assay were Salmonella typhimurium TA98, TA100, TA 102, TA1535 and TA1537.
Based on the experimental results obtained, the mean numbers of revertant colonies at the tested concentrations were comparable to those of the vehicle control, in both the trials, in the presence and absence of metabolic activation. There was no appreciable increase in number of revertant colonies at any of the tested concentrations in both the trials.
The number of revertant colonies in the positive controls resulted in 2.1 to 18.3 fold increase under identical conditions.
Conclusion
Based on the results obtained, it can be concluded that the test item is “non-mutagenic” in the Bacterial Reverse Mutation Test, up to the highest tested concentration of 5 mg/plate and under the test conditions.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
IN VITRO GENE MUTATION STUDY IN BACTERIA
Acid Blue 280 was evaluated for mutagenicity in Bacterial Reverse Mutation Test, according to OECD guideline 471 (1997). On the basis of test item solubility and precipitation tests, the initial cytotoxicity test was performed at 0.5, 0.6, 0.7, 0.8, 0.9, 1, 2, 3, 4 and 5 mg/plate. Initial cytotoxicity test was performed with TA100 both in the presence and absence of metabolic activation system; no cytotoxicity was recorded when compared to vehicle control. On the basis of preliminary results, 5 mg/plate was considered as the highest test concentration for mutation assay.
Two independent trials (trial 1 and 2) were conducted by plate incorporation and pre incubation methods, in the presence and absence of metabolic activation system. The tester strains used in the mutation assay were Salmonella typhimurium TA98, TA100, TA 102, TA1535 and TA1537. Based on the experimental results obtained, the mean numbers of revertant colonies at the tested concentrations were comparable to those of the vehicle control, in both the trials, in the presence and absence of metabolic activation. There was no appreciable increase in number of revertant colonies at any of the tested concentrations in both the trials.
Based on the results obtained, it can be concluded that the test item is “non-mutagenic” in the Bacterial Reverse Mutation Test, up to the highest tested concentration of 5 mg/plate and under the test conditions.
In addition, data from a screening test is also available. It should be considered that the Acid Blue 280 content in the lot tested was low, thus reliabiity of the study results is not assessable.
The substance was tested for mutagenicity effects in Salmonella typhimurium TA98, TA100, TA1535 TA1537 and TA1538, with and without metabolic activation. The test consists in two experiments, i.e. range-finding experiment and experiment 1, conducted at the following concentrations of 1.6, 8, 40, 200, 1000 and 5000 μg/plate. A statistically significant increase in revertant numbers was observed following TA100 treatments in the presence of S-9 when the data from the range-finder experiment was analysed at the 1 % level using Dunnett's test. TA100 treatments were thus included in experiment 1, in order to investigate the reproducibility of this response. Following these treatments a small but statistically significant increase in revertant numbers was again observed following TA100 treatments in the presence of S-9. The maximum increase in revertant numbers was observed at the same dose in each experiment and this was considered to be probable evidence of test item weak mutagenic activity in this strain, under this treatment condition. No other test item treatments in this study induced statistically significant increases in revertant numbers, when the data were analysed at the 1 % level using Dunnett's test in experiment 1. No precipitation of test agent was observed following any of the treatments in either the presence or absence of S-9.
No evidence of toxicity, as would normally be indicated by a thinning of the background bacterial lawn or a marked decrease in revertant numbers was observed following any of the treatments in either the presence or the absence of S-9.
The outcomes of this second study were not confirmed by the key experiment, which was conducted on a more representative batch; therefore, this study was disregarded.
Justification for classification or non-classification
According to the CLP Regulation (EC 1272/2008), for the purpose of the classification for germ cell mutagenicity, substances are allocated in one of two categories in consideration of the fact that they are:
- substances known to induce heritable mutations or to be regarded as if they induce heritable mutations in the germ cells of humans or substances known to induce heritable mutations in the germ cells of humans or
- substances which cause concern for humans owing to the possibility that they may induce heritable mutations in the germ cells of humans.
The available information suggest that test substance did not show any reasons of concern from the genotoxicity point of view.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.